Li, Wende
Li, Sen
Chen, Ivy X.
Liu, Yujiao
Ramjiawan, Rakesh R.
Leung, Chi-Ho
Gerweck, Leo E.
Fukumura, Dai
Loeffler, Jay S.
Jain, Rakesh K.
Duda, Dan G.
Huang, Peigen http://orcid.org/0000-0002-3184-6493
Funding for this research was provided by:
National Institutes of Health (P01-CA080124)
Article History
Received: 17 August 2020
Accepted: 23 February 2021
First Online: 4 March 2021
Declarations
:
: Not human participants, human data and human tissue were involving this study. All animals used in this study was approved by the Institutional Animal Care and Use Committee (IACUC) in Massachusetts General Hospital.
: Not applicable.
: RKJ received honorarium from Amgen and consultant fees from Chugai, Elpis, Ophthotech, Merck, SPARC, and SynDevRx; owns equity in Accurius, Enlight, SPARC, and SynDevRx, and serves on the Boards of Trustees of Tekla Healthcare Investors, Tekla Life Sciences Investors, Tekla Healthcare Opportunities Fund and Tekla World Healthcare Fund. RKJ and DF received a research grant from Boehringer Ingelheim. DF received consultant fees from Merck. DGD received consultant fees from Bayer, Simcere, Surface Oncology and BMS and research grants from Bayer, Exelixis and BMS. No funding or reagents from these companies were used in this study.